Opioids/cannabinoids as a potential therapeutic approach in COVID-19 patients

Expert Rev Respir Med. 2020 Oct;14(10):965-967. doi: 10.1080/17476348.2020.1787836. Epub 2020 Jun 30.

Authors

Alireza Tahamtan^{1 2}, Masoumeh Tavakoli-Yaraki³, Vahid Salimi⁴

Affiliations

¹ Infectious Diseases Research Centre, Golestan University of Medical Sciences , Gorgan, Iran.
² Department of Microbiology, School of Medicine, Golestan University of Medical Sciences , Gorgan, Iran.
³ Department of Biochemistry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
⁴ Department of Virology, School of Public Health, Tehran University of Medical Sciences , Tehran, Iran.

No abstract available

Keywords: COVID-19; Cannabinoids; RSV; immunomodulators; opioids.

Publication types

Editorial

Grants and funding

This paper was not funded.